Clinical Trial Update: Telmisartan in Combination With Cytotoxic Regimens in Platinum-Resistant Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating telmisartan in combination with cytotoxic chemotherapy for platinum-resistant ovarian cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Telmisartan (Telmisartan)

Snippet

Sponsor: Tyler J Curiel | Conditions: Ovarian Cancer | Phase 2 | Status: RECRUITING